BIOMAT Database Logo BIOMAT Database Logo

Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations. 2012

Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Discovery Medicine CVU CEDD, GlaxoSmithKline, Department of Discovery Medicine, 709 Swedeland Rd, UW2301, King of Prussia, PA 19406, USA. esther.ooi@uwa.edu.au

OBJECTIVE We investigated the impact of lipoprotein lipase (LPL) gene mutations on apolipoprotein B (apoB)-100 metabolism. RESULTS We studied 3 subjects with familial LPL deficiency; 14 subjects heterozygous for the LPL gene mutations Gly188Glu, Trp64Stop, and Ile194Thr; and 10 control subjects. Very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL)-apoB-100 kinetics were determined in the fed state using stable isotope methods and compartmental modeling. Compared with controls, familial LPL deficiency had markedly elevated plasma triglycerides and lower VLDL-apoB-100 fractional catabolic rate (FCR), IDL-apoB-100 FCR, VLDL-to-IDL conversion, and VLDL-apoB-100 production rate (P<0.01). Compared with controls, Gly188Glu had higher plasma triglyceride and VLDL- and IDL-apoB-100 concentrations and lower VLDL- and IDL-apoB-100 FCR (P<0.05). Plasma triglycerides were not different, but IDL-apoB-100 concentration and production rate and VLDL-to-IDL conversion were lower in Trp64Stop compared with controls (P<0.05). No differences between controls and Ile194Thr were observed. CONCLUSIONS Our results confirm that hypertriglyceridemia is a key feature of familial LPL deficiency. This is due to impaired VLDL- and IDL-apoB-100 catabolism and VLDL-to-IDL conversion. Single-allele mutations of the LPL gene result in modest to elevated plasma triglycerides. The changes in plasma triglycerides and apoB-100 kinetics are attributable to the effects of the LPL genotype.

UI MeSH Term Description Entries
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008659 Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) Thesaurismosis,Diseases, Metabolic,Disease, Metabolic,Metabolic Disease,Thesaurismoses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes

Related Publications

Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis.
January 2001, Physiological research,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
January 1996, Biochimica et biophysica acta,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells.
February 1994, Arteriosclerosis and thrombosis : a journal of vascular biology,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
November 1993, Atherosclerosis,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
October 2008, Metabolism: clinical and experimental,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
November 1991, The Journal of clinical investigation,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice.
August 1998, Journal of lipid research,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Lipoprotein metabolism in subjects with hepatic lipase deficiency.
April 2004, Metabolism: clinical and experimental,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.
July 1991, Kidney international,
Esther M M Ooi, and Betsy S Russell, and Eric Olson, and Sam Z Sun, and Margaret R Diffenderfer, and Alice H Lichtenstein, and Leonard Keilson, and P Hugh R Barrett, and Ernst J Schaefer, and Dennis L Sprecher
Is vitellogenin an ancestor of apolipoprotein B-100 of human low-density lipoprotein and human lipoprotein lipase?
November 1988, The Biochemical journal,
Copied contents to your clipboard!